Sir,
We describe two cases of disturbed visual perception during treatment of heart failure with captopril and enalapril.
Case I A 73 year old man was commenced on enalapril 5 mg twice a day when he developed pulmonary oedema 2 months after an anterior myocardial infarction. His only other medications were frusemide 80 mg and aspirin 300 Reports are also scarce in the literature. One paper' described confusion and hallucinations in a 76 year old man given captopril 37.5 mg daily for severe heart failure. Reduction in dosage did not help but intravenous naloxone completely restored mental functioning. It was suggested that captopril inhibited enkephenyl dipeptidyl carboxypeptidase (EDCP) thus enhancing opioid activity. The Swedish Adverse Reactions Committee has also published the case of a 49 year old woman who developed confusion, headache and hallucinations within one week of starting captopril therapy. She was well 12 days after stopping treatment.2 One report of unpleasant dreams with enalapril has also been recorded. 3 Elderly people with cardiac failure often present with atypical symptoms such as somnolence, confusion, disorientation and falls because their central nervous and musculoskeletal systems are more sensitive to a fall in cardiac output. Such symptoms developing during therapy might not be readily attributed to medications. We thus encourage greater vigilance in recognizing this adverse effect of ACE inhibitors. It may not be readily volunteered, could impair compliance with treatment and may cause considerable distress.
